EFFICACY AND SAFETY OF ERYTHROPOIETIN (EPO) IN ANEMIA OF PREMATURITY - A RANDOMIZED PLACEBO-CONTROLLED STUDY

被引:0
|
作者
KUMAR, P [1 ]
CHINNAKRISHNAN, R [1 ]
SHANKARAN, S [1 ]
机构
[1] WAYNE STATE UNIV,DEPT PEDIAT,DETROIT,MI 48202
来源
CLINICAL RESEARCH | 1994年 / 42卷 / 03期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A433 / A433
页数:1
相关论文
共 50 条
  • [1] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA OF PREMATURITY - RESULTS OF A PLACEBO-CONTROLLED PILOT-STUDY
    SHANNON, KM
    MENTZER, WC
    ABELS, RI
    FREEMAN, P
    NEWTON, N
    THOMPSON, D
    SNIDERMAN, S
    BALLARD, R
    PHIBBS, RH
    JOURNAL OF PEDIATRICS, 1991, 118 (06): : 949 - 955
  • [2] PLACEBO-CONTROLLED TRIAL OF ERYTHROPOIETIN (EPO) FOR NEWBORN LAMBS
    PETERS, C
    GEORGIEFF, MK
    DEALARCON, P
    WIDNESS, JA
    PEDIATRIC RESEARCH, 1994, 35 (04) : A168 - A168
  • [3] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF THE ANEMIA OF PREMATURITY - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MEYER, MP
    MEYER, JH
    COMMERFORD, A
    HANN, FM
    SIVE, AA
    MOLLER, G
    JACOBS, P
    MALAN, AF
    PEDIATRICS, 1994, 93 (06) : 918 - 923
  • [4] Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study
    Krause, Karoline
    Tsianakas, Athanasios
    Wagner, Nicola
    Fischer, Joerg
    Weller, Karsten
    Metz, Martin
    Church, Martin K.
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (04) : 1311 - 1320
  • [5] Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study
    Camilleri, Michael
    McCallum, Richard W.
    Tack, Jan
    Spence, Sharon C.
    Gottesdiener, Keith
    Fiedorek, Fred T.
    GASTROENTEROLOGY, 2017, 153 (05) : 1240 - +
  • [6] A randomized, placebo-controlled, multicenter study of the safety and efficacy of Braintree 851 laxative
    DiPalma, JA
    DeRidder, PH
    Orlando, RC
    Kolts, BE
    Cleveland, MVB
    GASTROENTEROLOGY, 1997, 112 (04) : A722 - A722
  • [7] Efficacy and safety of patiromer for hyperkalemia: a randomized, placebo-controlled phase 3 study
    Kashihara, Naoki
    Okada, Hirokazu
    Suzuki, Yusuke
    Iwamoto, Tamio
    Yasutomi, Masashi
    Matsui, Masaru
    Takezawa, Ryo
    Ishii, Takayuki
    Tomioka, Yusuke
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2025,
  • [8] Early vs. Late Recombinant Human Erythropoietin (rHuEPO) in Anemia of Prematurity: Results of a Randomized, Placebo-Controlled, Multicentric Trial • 1383
    H Donato
    N Vivas
    N Vain
    L Prudent
    M Larguía
    J DiGregorio
    C Vecchiarelli
    R Valverde
    P Rondo
    C Garcia
    P Subotovsky
    C Solana
    A Gorenstein
    Pediatric Research, 1998, 43 (Suppl 4) : 236 - 236
  • [9] Recombinant human erythropoietin in the treatment of anemia of prematurity: A randomized, double-blind, placebo-controlled trial comparing three different doses
    Donato, H
    Rendo, P
    Vivas, N
    Schvartzman, G
    Digregorio, J
    Vain, N
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1996, 3 (04): : 279 - 285
  • [10] TREATMENT OF THE ANEMIA OF PREDIALYSIS PATIENTS WITH RECOMBINANT HUMAN ERYTHROPOIETIN - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    STONE, WJ
    GRABER, SE
    KRANTZ, SB
    DESSYPRIS, EN
    ONEIL, VL
    OLSEN, NJ
    PINCUS, TP
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (03): : 171 - 179